In this SPARK-BIH National Gene and Cell Therapies Webinar, Dr. Stefan Frank will present an in-depth overview of bemdaneprocel, one of the first PSC-derived therapies to reach pivotal clinical trials. He will outline the scientific, regulatory, and clinical milestones that guided its path from concept to clinic and highlight the collaboration between BlueRock Therapeutics and Bayer as a model for effective Biotech–Pharma partnerships. The session will address key drivers of success in emerging ATMP programs such as manufacturing, trial design, and collaboration strategy, and provide practical insights for translational teams advancing their own GCT innovations.
Please register HERE
More information can be found in the attached flyer.
